French multicentre experience of implantable insulin pumps

Limitations of intensive diabetes treatment with subcutaneous insulin include achievement of only near-normoglycaemia and increased risk of hypoglycaemia. Programmable implantable pumps permit variable rates of intraperitoneal insulin infusion. The French experience represents 224 type I adult diabe...

Full description

Saved in:
Bibliographic Details
Published in:The Lancet (British edition) 1994-02, Vol.343 (8896), p.514-515
Main Authors: Broussolle, C., Jeandidier, N., Hanaire-Broutin, H.
Format: Article
Language:English
Subjects:
Biological and medical sciences
Diabetes
Hormones. Endocrine system
Insulin
Medical research
Medical sciences
Pharmacology. Drug treatments
Pumps
Transplants & implants
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Limitations of intensive diabetes treatment with subcutaneous insulin include achievement of only near-normoglycaemia and increased risk of hypoglycaemia. Programmable implantable pumps permit variable rates of intraperitoneal insulin infusion. The French experience represents 224 type I adult diabetic patients followed up for 353 patient-years in seven centres. Compared with pre-implantation values with intensive subcutaneous insulin, glycaemic control was significantly improved with implantable pumps: glycosylated haemoglobin fell from 7·4 (1·8)% to 6·8 (1·0)% at 6 months (mean, SD, p
ISSN:0140-6736
1474-547X
DOI:10.1016/S0140-6736(94)91462-1